Modulation of gut microbiota, up-regulation of ZO-1, and promotion of metabolism as therapeutic mechanisms of indole-3-carbinol against obesity in mice

BackgroundIndole-3-carbinol (I3C) is a compound derived from Cruciferous vegetables. We aim to ascertain whether I3C mediates the relations between mouse gut microbiota, intestinal barrier function, and metabolism to treat obesity in mice.MethodsThe experimental analyses focused on the changes in li...

Full description

Saved in:
Bibliographic Details
Main Authors: XuWen Mao, Guliruoyi Paerhati, Yuche Wu, Lu Feng Cheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1499142/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841561069326172160
author XuWen Mao
Guliruoyi Paerhati
Yuche Wu
Lu Feng Cheng
author_facet XuWen Mao
Guliruoyi Paerhati
Yuche Wu
Lu Feng Cheng
author_sort XuWen Mao
collection DOAJ
description BackgroundIndole-3-carbinol (I3C) is a compound derived from Cruciferous vegetables. We aim to ascertain whether I3C mediates the relations between mouse gut microbiota, intestinal barrier function, and metabolism to treat obesity in mice.MethodsThe experimental analyses focused on the changes in lipid distribution, inflammatory cytokines, glucose tolerance, gut microbiota composition, and serum metabolomics of 60 C57BL/6N mice.ResultsThe experimental results demonstrated that I3C reduced body weight, hepatic steatosis, and systemic inflammation and improved insulin resistance in mice on a high-fat diet (HFD). Furthermore, I3C remarkably enhanced the enrichment of probiotics Akkermansia and Ligilactobacillus as well as SCFA-producing bacteria (Eubacterium, Lactococcus, and Coprococcus), while reducing the abundance of Eisenbergiella and Rikenellaceae_RC9_gut_group. Also, I3C notably up-regulated the levels of Claudin4, Occludin, and ZO-1 proteins and modulated the metabolism of argininosuccinic acid and galactose.ConclusionThe aforementioned findings suggest that I3C exerts a significant anti-obesity effect in mice by regulating abnormal gut microbiome, enhancing intestinal barrier function, and improving metabolic disorders.
format Article
id doaj-art-d964b7d9edc74a0aaaac8ed0f6c8bda9
institution Kabale University
issn 1663-9812
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-d964b7d9edc74a0aaaac8ed0f6c8bda92025-01-03T06:47:24ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-01-011510.3389/fphar.2024.14991421499142Modulation of gut microbiota, up-regulation of ZO-1, and promotion of metabolism as therapeutic mechanisms of indole-3-carbinol against obesity in miceXuWen Mao0Guliruoyi Paerhati1Yuche Wu2Lu Feng Cheng3College of Pharmacy, Xinjiang Key Laboratory of Biopharmaceuticals and Medical Devices, Xinjiang Medical University, Ürümqi, ChinaCollege of Pharmacy, Xinjiang Key Laboratory of Biopharmaceuticals and Medical Devices, Xinjiang Medical University, Ürümqi, ChinaXinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences (CAS), Ürümqi, ChinaCollege of Pharmacy, Xinjiang Key Laboratory of Biopharmaceuticals and Medical Devices, Xinjiang Medical University, Ürümqi, ChinaBackgroundIndole-3-carbinol (I3C) is a compound derived from Cruciferous vegetables. We aim to ascertain whether I3C mediates the relations between mouse gut microbiota, intestinal barrier function, and metabolism to treat obesity in mice.MethodsThe experimental analyses focused on the changes in lipid distribution, inflammatory cytokines, glucose tolerance, gut microbiota composition, and serum metabolomics of 60 C57BL/6N mice.ResultsThe experimental results demonstrated that I3C reduced body weight, hepatic steatosis, and systemic inflammation and improved insulin resistance in mice on a high-fat diet (HFD). Furthermore, I3C remarkably enhanced the enrichment of probiotics Akkermansia and Ligilactobacillus as well as SCFA-producing bacteria (Eubacterium, Lactococcus, and Coprococcus), while reducing the abundance of Eisenbergiella and Rikenellaceae_RC9_gut_group. Also, I3C notably up-regulated the levels of Claudin4, Occludin, and ZO-1 proteins and modulated the metabolism of argininosuccinic acid and galactose.ConclusionThe aforementioned findings suggest that I3C exerts a significant anti-obesity effect in mice by regulating abnormal gut microbiome, enhancing intestinal barrier function, and improving metabolic disorders.https://www.frontiersin.org/articles/10.3389/fphar.2024.1499142/fullindole-3-carbinolgut microantha biotaobesityserum metabolomicsZO-1
spellingShingle XuWen Mao
Guliruoyi Paerhati
Yuche Wu
Lu Feng Cheng
Modulation of gut microbiota, up-regulation of ZO-1, and promotion of metabolism as therapeutic mechanisms of indole-3-carbinol against obesity in mice
Frontiers in Pharmacology
indole-3-carbinol
gut microantha biota
obesity
serum metabolomics
ZO-1
title Modulation of gut microbiota, up-regulation of ZO-1, and promotion of metabolism as therapeutic mechanisms of indole-3-carbinol against obesity in mice
title_full Modulation of gut microbiota, up-regulation of ZO-1, and promotion of metabolism as therapeutic mechanisms of indole-3-carbinol against obesity in mice
title_fullStr Modulation of gut microbiota, up-regulation of ZO-1, and promotion of metabolism as therapeutic mechanisms of indole-3-carbinol against obesity in mice
title_full_unstemmed Modulation of gut microbiota, up-regulation of ZO-1, and promotion of metabolism as therapeutic mechanisms of indole-3-carbinol against obesity in mice
title_short Modulation of gut microbiota, up-regulation of ZO-1, and promotion of metabolism as therapeutic mechanisms of indole-3-carbinol against obesity in mice
title_sort modulation of gut microbiota up regulation of zo 1 and promotion of metabolism as therapeutic mechanisms of indole 3 carbinol against obesity in mice
topic indole-3-carbinol
gut microantha biota
obesity
serum metabolomics
ZO-1
url https://www.frontiersin.org/articles/10.3389/fphar.2024.1499142/full
work_keys_str_mv AT xuwenmao modulationofgutmicrobiotaupregulationofzo1andpromotionofmetabolismastherapeuticmechanismsofindole3carbinolagainstobesityinmice
AT guliruoyipaerhati modulationofgutmicrobiotaupregulationofzo1andpromotionofmetabolismastherapeuticmechanismsofindole3carbinolagainstobesityinmice
AT yuchewu modulationofgutmicrobiotaupregulationofzo1andpromotionofmetabolismastherapeuticmechanismsofindole3carbinolagainstobesityinmice
AT lufengcheng modulationofgutmicrobiotaupregulationofzo1andpromotionofmetabolismastherapeuticmechanismsofindole3carbinolagainstobesityinmice